CD3Z高甲基化与系统性红斑狼疮严重临床表现相关并降低T细胞CD3ζ链表达
该研究通过微阵列筛选SLE全血DNA甲基化标记,在两个独立族裔队列(207例SLE患者和151例对照)中确认CD3Z和VHL高甲基化与SLE显著相关。CD3Z高甲基化与SLE疾病活动指数更高及蛋白尿、溶血性贫血、血小板减少等更严重临床表现相关,并与SLE T细胞中CD3ζ链下调相关。
要点
- CD3Z高甲基化与SLE风险显著相关(OR=7.76;P=1.71×10^-13)。
- CD3Z高甲基化与更高SLE疾病活动指数和更严重临床表现相关。
- CD3Z高甲基化与SLE T细胞中CD3ζ链下调相关。
核心结论
- CD3Z高甲基化是SLE风险因素,可受环境因素修饰,并与更严重的SLE临床表现相关,其机制与下调CD3ζ链导致T细胞功能紊乱有关。
研究设计与样本
- 通过微阵列筛选SLE全血DNA甲基化标记,并在两个独立族裔队列(207例SLE患者和151例对照)中用甲基化单碱基延伸法确认两个标记。
主要发现
- CD3Z高甲基化与SLE显著相关(OR=7.76;P=1.71×10^-13),VHL高甲基化也与SLE显著相关(OR=3.77;P=3.20×10^-8)。
- CD3Z甲基化升高与SLE T细胞中CD3ζ链下调相关。
- 纵向和双样本分析显示CD3Z甲基化受遗传影响小于VHL甲基化。
- CD3Z甲基化水平更高与更高SLE疾病活动指数及蛋白尿、溶血性贫血、血小板减少等更严重临床表现显著相关,而VHL高甲基化无此关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The importance of hypomethylation in SLE is well recognized; however, the significance of hypermethylation has not been well characterized. We screened hypermethylated marks in SLE and investigated their possible implications. METHODS: DNA methylation marks were screened in SLE whole-blood DNA by microarray, and two marks ( CD3Z and VHL hypermethylations) were confirmed by a methylation single-base extension method in two independent ethnic cohorts consisting of 207 SLE patients and 151 controls. The correlation with clinical manifestations and the genetic influence on those epigenetic marks were analysed. RESULTS: Two epigenetic marks, CD3Z and VHL hypermethylation, were significantly correlated with SLE: CD3Z hypermethylation (odds ratio = 7.76; P = 1.71 × 10 -13 ) and VHL hypermethylation (odds ratio = 3.77; P = 3.20 × 10 -8 ), and the increased CD3Z methylation was correlated with downregulation of the CD3ζ-chain in SLE T cells. In addition, less genetic influence on CD3Z methylation relative to VHL methylation was found in analyses of longitudinal and twin samples. Furthermore, a higher CD3Z methylation level was significantly correlated with a higher SLE disease activity index and more severe clinical manifestations, such as proteinuria, haemolytic anaemia and thrombocytopenia, whereas VHL hypermethylation was not. CONCLUSION: CD3Z hypermethylation is an SLE risk factor that can be modified by environmental factors and is associated with more severe SLE clinical manifestations, which are related to deranged T cell function by downregulating the CD3ζ-chain.
引用
- Hong KM, Kim HK, Park SY, et al. CD3Z hypermethylation is associated with severe clinical manifestations in systemic lupus erythematosus and reduces CD3ζ-chain expression in T cells. Rheumatology (Oxford). 2017. PMID: 27940592. doi:10.1093/rheumatology/kew405
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。